Armand Keating
#114,936
Most Influential Person Now
Researcher ORCID ID = 0000-0002-7676-6059
Armand Keating's AcademicInfluence.com Rankings
Armand Keatingengineering Degrees
Engineering
#3447
World Rank
#4527
Historical Rank
Biomedical Engineering
#163
World Rank
#168
Historical Rank
Applied Physics
#637
World Rank
#657
Historical Rank
Download Badge
Engineering
Why Is Armand Keating Influential?
(Suggest an Edit or Addition)Armand Keating's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. (2006) (14777)
- Acute myeloid leukemia. (2002) (3265)
- Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. (2005) (1906)
- Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. (2004) (1541)
- Mesenchymal stromal cells: new directions. (2012) (710)
- Mesenchymal stromal cells (2006) (694)
- A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome. (2004) (620)
- Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. (2006) (539)
- Bone marrow-derived mesenchymal stromal cells for the repair of central nervous system injury (2007) (460)
- Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndrome. (2010) (444)
- Concise Review: Hitting the Right Spot with Mesenchymal Stromal Cells (2010) (374)
- Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure. (2010) (372)
- Defining the risks of mesenchymal stromal cell therapy. (2010) (284)
- Bone marrow transplantation from HLA-identical siblings as treatment for myelodysplasia. (2002) (260)
- Donor origin of the in vitro haematopoietic microenvironment after marrow transplantation in man (1982) (256)
- Glycogen synthase kinase 3β missplicing contributes to leukemia stem cell generation (2009) (251)
- Human Mesenchymal Stem Cells Self-Renew and Differentiate According to a Deterministic Hierarchy (2009) (235)
- Mesenchymal stromal cells mediate a switch to alternatively activated monocytes/macrophages after acute myocardial infarction (2011) (234)
- Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia. (2000) (222)
- Bone Marrow‐Derived Mesenchymal Stromal Cells Express Cardiac‐Specific Markers, Retain the Stromal Phenotype, and Do Not Become Functional Cardiomyocytes In Vitro (2008) (220)
- Isolated Chloroma: The Effect of Early Antileukemic Therapy (1995) (215)
- Autologous transplantation for diffuse aggressive non-Hodgkin's lymphoma in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry. (2001) (215)
- Sensitive detection and enumeration of CD34+ cells in peripheral and cord blood by flow cytometry. (1994) (213)
- Normal and leukemic SCID-repopulating cells (SRC) coexist in the bone marrow and peripheral blood from CML patients in chronic phase, whereas leukemic SRC are detected in blast crisis. (1996) (202)
- The CD34 antigen: structure, biology, and potential clinical applications. (1992) (202)
- High level engraftment of NOD/SCID mice by primitive normal and leukemic hematopoietic cells from patients with chronic myeloid leukemia in chronic phase. (1998) (200)
- Biology of Bone Marrow Stroma (1995) (194)
- Autotransplants for Hodgkin's disease in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry. (1999) (194)
- Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study. (2003) (190)
- A comparison of cyclophosphamide and total body irradiation with etoposide and total body irradiation as conditioning regimens for patients undergoing sibling allografting for acute lymphoblastic leukemia in first or second complete remission. (2006) (174)
- Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia. (2010) (172)
- Doxorubicin‐Conjugated Immuno‐Nanoparticles for Intracellular Anticancer Drug Delivery (2009) (171)
- The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myelogenous leukemia in adults: an evidence-based review. (2008) (167)
- Electric field-mediated DNA transfer: transient and stable gene expression in human and mouse lymphoid cells (1986) (162)
- Androgen-induced inhibition of cell proliferation in an androgen-insensitive prostate cancer cell line (PC-3) transfected with a human androgen receptor complementary DNA. (1993) (152)
- Concise Review: Wharton's Jelly: The Rich, but Enigmatic, Source of Mesenchymal Stromal Cells (2017) (142)
- How I treat relapsed and refractory Hodgkin lymphoma. (2011) (132)
- Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia. (2008) (131)
- Identification of a bone marrow-derived epithelial-like population capable of repopulating injured mouse airway epithelium. (2009) (131)
- ABO blood group barrier in allogeneic bone marrow transplantation revisited. (2005) (120)
- Effect of postremission chemotherapy before human leukocyte antigen-identical sibling transplantation for acute myelogenous leukemia in first complete remission. (2000) (120)
- Proteoglycans in human long-term bone marrow cultures: biochemical and ultrastructural analyses. (1986) (117)
- Autologous stem cell transplant for relapsed and refractory peripheral T‐cell lymphoma: variable outcome according to pathological subtype (2003) (117)
- Rosuvastatin, identified from a zebrafish chemical genetic screen for antiangiogenic compounds, suppresses the growth of prostate cancer. (2010) (115)
- Meropenem versus ceftazidime in the treatment of cancer patients with febrile neutropenia: a randomized, double-blind trial. (2000) (107)
- Bone Marrow Mesenchymal Stromal Cell Treatment in Patients with Osteoarthritis Results in Overall Improvement in Pain and Symptoms and Reduces Synovial Inflammation (2019) (106)
- TLR3 or TLR4 Activation Enhances Mesenchymal Stromal Cell‐Mediated Treg Induction via Notch Signaling (2016) (105)
- Immuno-polymeric nanoparticles by Diels-Alder chemistry. (2007) (104)
- Mini-BEAM as salvage therapy for relapsed or refractory Hodgkin's disease before intensive therapy and autologous bone marrow transplantation. (1995) (103)
- Stable expression of selectable genes introduced into human hematopoietic stem cells by electric field-mediated DNA transfer. (1986) (102)
- Differential sensitivity of CD34 epitopes to cleavage by Pasteurella haemolytica glycoprotease: implications for purification of CD34-positive progenitor cells. (1992) (100)
- Comparison of outcome following allogeneic bone marrow transplantation with cyclophosphamide–total body irradiation versus busulphan–cyclophosphamide conditioning regimens for acute myelogenous leukaemia in first remission (2002) (99)
- High treatment-related mortality in cardiac amyloid patients undergoing autologous stem cell transplant (1999) (97)
- Exosomes released by hepatocarcinoma cells endow adipocytes with tumor-promoting properties (2018) (95)
- How do mesenchymal stromal cells suppress T cells? (2008) (91)
- KHYG-1, a model for the study of enhanced natural killer cell cytotoxicity. (2005) (91)
- Intravenously Administered Bone Marrow Cells Migrate to Damaged Brain Tissue and Improve Neural Function in Ischemic Rats (2007) (90)
- Similar response rates and superior early progression‐free survival with gemcitabine, dexamethasone, and cisplatin salvage therapy compared with carmustine, etoposide, cytarabine, and melphalan salvage therapy prior to autologous stem cell transplantation for recurrent or refractory Hodgkin lymphoma (2006) (89)
- Ovarian function after autologous bone marrow transplantation. (1998) (88)
- Autotransplants for histologically transformed follicular non‐Hodgkin's lymphoma (2001) (86)
- Exosomes secreted by mesenchymal stromal/stem cell-derived adipocytes promote breast cancer cell growth via activation of Hippo signaling pathway (2019) (86)
- Simian virus 40-transformed adherent cells from human long-term marrow cultures: cloned cell lines produce cells with stromal and hematopoietic characteristics. (1987) (85)
- Unrelated donor transplants in adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission. (2008) (81)
- Salvage chemotherapy and autologous stem cell transplantation are inferior for relapsed or refractory primary mediastinal large B-cell lymphoma compared with diffuse large B-cell lymphoma (2008) (81)
- Chemotherapy versus transplants for acute myelogenous leukemia in second remission. (1996) (80)
- CD34 antigen: Molecular features and potential clinical applications (1993) (79)
- Peripheral blood progenitor cell collections in multiple myeloma: predictors and management of inadequate collections (1996) (79)
- Oligodendrocytes and Radial Glia Derived From Adult Rat Spinal Cord Progenitors: Morphological and Immunocytochemical Characterization (2007) (79)
- Beyond maximum grade: modernising the assessment and reporting of adverse events in haematological malignancies. (2018) (78)
- Variable transcription of BCR-ABL by Ph+ cells arising from hematopoietic progenitors in chronic myeloid leukemia. (1994) (77)
- Human Vδ1 γδ T cells expanded from peripheral blood exhibit specific cytotoxicity against B-cell chronic lymphocytic leukemia-derived cells. (2011) (77)
- The Role of Intensive Therapy and Autologous Blood and Marrow Transplantation for Chemotherapy‐Sensitive Relapsed and Primary Refractory Non‐Hodgkin’s Lymphoma: Identification of Major Prognostic Groups (1996) (76)
- Mesenchymal Stem/Stromal Cells Induce the Generation of Novel IL-10–Dependent Regulatory Dendritic Cells by SOCS3 Activation (2012) (75)
- Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete remission. (2007) (75)
- Treatment of acute myeloid leukemia cells in vitro with a monoclonal antibody recognizing a myeloid differentiation antigen allows normal progenitor cells to be expressed. (1987) (75)
- Autologous stem cell transplantation in multiple myeloma patients <60 vs ⩾60 years of age (2003) (73)
- Activation of c‐kit is necessary for mobilization of reparative bone marrow progenitor cells in response to cardiac injury (2008) (72)
- Fate of transplanted adult neural stem/progenitor cells and bone marrow-derived mesenchymal stromal cells in the injured adult rat spinal cord and impact on functional recovery. (2008) (72)
- Nonhematopoietic mesenchymal stem cells: what are they? (2000) (71)
- CGA-7 and HHF, two monoclonal antibodies that recognize muscle actin and react with adherent cells in human long-term bone marrow cultures. (1985) (69)
- Current use and trends in hematopoietic cell transplantation (2017) (67)
- Expression of p210 and p190 BCR‐ABL due to alternative splicing in chronic myelogenous leukaemia (1998) (66)
- Autotransplants in chronic myelogenous leukaemia: strategies and results (1990) (66)
- Harmonizing standards for producing clinical-grade therapies from pluripotent stem cells (2014) (65)
- Hematopoietic stem cells engraft in untreated transplant recipients. (1993) (63)
- Mesenchymal stromal cells for graft-versus-host disease. (2011) (63)
- Microbial contamination of harvested bone marrow and peripheral blood. (1995) (63)
- Second autologous stem cell transplantation for relapsed lymphoma after a prior autologous transplant. (2008) (62)
- Culture-Modified Bone Marrow Cells Attenuate Cardiac and Renal Injury in a Chronic Kidney Disease Rat Model via a Novel Antifibrotic Mechanism (2010) (62)
- A phase I trial of NK-92 cells for refractory hematological malignancies relapsing after autologous hematopoietic cell transplantation shows safety and evidence of efficacy (2017) (62)
- Evidence for a stem cell common to hematopoiesis and its in vitro microenvironment: studies of patients with clonal hematopoietic neoplasia. (1984) (62)
- Osteoporosis after blood and marrow transplantation: clinical aspects. (2000) (61)
- Salvage chemotherapy with mini-BEAM for relapsed or refractory non-Hodgkin's lymphoma prior to autologous bone marrow transplantation. (1997) (61)
- Intravenously administered bone marrow cells migrate to damaged brain tissue and improve neural function in ischemic rats. (2008) (61)
- The generation of human long-term marrow cultures from marrow depleted of Ia (HLA-DR) positive cells. (1984) (61)
- A phase I trial of NK-92 cells for refractory hematological malignancies relapsing after autologous hematopoietic cell transplantation shows safety and evidence of efficacy. (2017) (60)
- Allogeneic bone marrow mesenchymal stem cell transplantation in patients with UDCA-resistant primary biliary cirrhosis. (2014) (60)
- Autologous versus allogeneic unrelated donor transplantation for acute lymphoblastic leukemia: comparative toxicity and outcomes. (2002) (59)
- Ketoconazole: a possible direct cytotoxic effect on prostate carcinoma cells. (1989) (58)
- Airway regeneration: the role of the Clara cell secretory protein and the cells that express it. (2009) (57)
- Effect of different promoters on expression of genes introduced into hematopoietic and marrow stromal cells by electroporation. (1990) (56)
- Autotransplantation versus HLA‐matched unrelated donor transplantation for acute myeloid leukaemia: a retrospective analysis from the Center for International Blood and Marrow Transplant Research (2006) (56)
- Analysis of Green Fluorescent Protein Expression in Transgenic Rats for Tracking Transplanted Neural Stem/Progenitor Cells (2005) (56)
- Autologous blood cell transplantation versus HLA-identical sibling transplantation for acute myeloid leukemia in first complete remission: a registry study from the Center for International Blood and Marrow Transplantation Research (2013) (55)
- Acquired Natural Killer Cell Dysfunction in the Tumor Microenvironment of Classic Hodgkin Lymphoma (2018) (55)
- Natural killer cell lines preferentially kill clonogenic multiple myeloma cells and decrease myeloma engraftment in a bioluminescent xenograft mouse model (2012) (54)
- Immunomodulatory Properties of Coriolus versicolor: The Role of Polysaccharopeptide (2017) (54)
- Allogeneic hematopoietic cell transplantation in human immunodeficiency virus-positive patients with hematologic disorders: a report from the center for international blood and marrow transplant research. (2009) (54)
- Salvage therapy for relapsed/refractory diffuse large B cell lymphoma. (2008) (53)
- High-Dose Chemotherapy and Autologous Stem-Cell Transplantation for Ovarian Cancer: An Autologous Blood and Marrow Transplant Registry Report (2000) (53)
- Electric field-mediated gene transfer: characterization of DNA transfer and patterns of integration in lymphoid cells. (1988) (51)
- Collagen scaffold enhances the regenerative properties of mesenchymal stromal cells (2017) (50)
- Intrathecal transplantation of stem cells by lumbar puncture for thoracic spinal cord injury in the rat (2011) (50)
- Responsiveness of the in vitro hematopoietic microenvironment to platelet-derived growth factor. (1985) (49)
- The effect of graft purging with 4-hydroperoxycyclophosphamide in autologous bone marrow transplantation for acute myelogenous leukemia. (2001) (48)
- Thoracic radiation therapy before autologous bone marrow transplantation in relapsed or refractory Hodgkin's disease. PMH Lymphoma Group, and the Toronto Autologous BMT Group. (1999) (48)
- Soliciting strategies for developing cell-based reference materials to advance mesenchymal stromal cell research and clinical translation. (2014) (47)
- A Prognostic Model Predicting Autologous Transplantation Outcomes in Children, Adolescents and Young Adults with Hodgkin Lymphoma (2015) (47)
- Phase II Trial of Lenalidomide in Patients with Relapsed or Refractory Hodgkin Lymphoma (2008) (46)
- Outcome of ethnic minorities with acute or chronic leukemia treated with hematopoietic stem-cell transplantation in the United States. (2005) (46)
- Decreased bone mineral density is common after autologous blood or marrow transplantation (2001) (45)
- Cultured marrow stromal cells express common acute lymphoblastic leukaemia antigen (CALLA): implications for marrow transplantation (1983) (45)
- Myeloablative conditioning regimens for AML allografts: 30 years later (2003) (45)
- Optimizing the CD34+ and CD34+Thy-1+ stem cell content of peripheral blood collections. (1995) (45)
- Extensive expansion of primary human gamma delta T cells generates cytotoxic effector memory cells that can be labeled with Feraheme for cellular MRI (2013) (44)
- HLA-identical sibling bone marrow transplants vs chemotherapy for acute myelogenous leukemia in first remission. (1996) (44)
- Anti-Leukemia Activity of In Vitro-Expanded Human Gamma Delta T Cells in a Xenogeneic Ph+ Leukemia Model (2011) (44)
- Radiation-associated pneumonitis following autologous stem cell transplantation: predictive factors, disease characteristics and treatment outcomes (2001) (44)
- Predictors of mortality in patients undergoing autologous hematopoietic cell transplantation admitted to the intensive care unit (2009) (44)
- Illness intrusiveness among survivors of autologous blood and marrow transplantation (2001) (44)
- Effect of radiation and cell implantation on wound healing in a rat model (2003) (43)
- Human Umbilical Cord Perivascular Cells Exhibit Enhanced Cardiomyocyte Reprogramming and Cardiac Function after Experimental Acute Myocardial Infarction (2013) (42)
- Effect of antimicrobial prophylaxis on hematopoietic recovery following autologous bone marrow transplantation: ciprofloxacin versus co-trimoxazole. (1995) (42)
- Lentivirus-mediated gene therapy for Fabry disease (2021) (41)
- Bead transfection of adherent cells (1996) (40)
- Long-term stable hematopoietic chimerism following marrow transplantation for acute lymphoblastic leukemia: a case report with in vitro marrow culture studies. (1983) (39)
- Gene transfer by electroporation: a model for gene therapy. (1990) (39)
- Differences in Origin of Reactive Microglia in Bone Marrow Chimeric Mouse and Rat After Transient Global Ischemia (2011) (39)
- Relearning the Lessons of Genomic Stability of Human Cells During Expansion in Culture: Implications for Clinical Research (2012) (39)
- Evaluation of cytoreductive therapy prior to high dose treatment with autologous bone marrow transplantation in relapsed and refractory Hodgkin's disease. (1990) (39)
- An official American Thoracic Society workshop report: stem cells and cell therapies in lung biology and diseases. (2015) (38)
- A functional defect in irradiated adherent layers from chronic myelogenous leukemia long-term marrow cultures. (1985) (38)
- Subdural Hematomas during CML Therapy with Imatinib Mesylate (2004) (38)
- Brief Report: The Potential Role of Epigenetics on Multipotent Cell Differentiation Capacity of Mesenchymal Stromal Cells (2013) (37)
- Detection and direct sequence identification of BCR-ABL mRNA in Ph+ chronic myeloid leukemia. (1993) (37)
- Mesenchymal stromal cells augment CD4+ and CD8+ T-cell proliferation through a CCL2 pathway. (2013) (37)
- Salvage chemotherapy and autologous stem cell transplant in primary refractory diffuse large B-cell lymphoma: outcomes and prognostic factors (2012) (36)
- PROGNOSTIC FACTORS FOR OUTCOMES IN ALLOGENEIC TRANSPLANTATION FOR ADVANCED PHASES OF CHRONIC MYELOID LEUKEMIA IN THE IMATINIB ERA: A CIBMTR ANALYSIS (2011) (36)
- Antibody Therapies for Acute Myeloid Leukemia: Unconjugated, Toxin-Conjugated, Radio-Conjugated and Multivalent Formats (2019) (34)
- ABL Kinase Inhibitor Therapy for CML : Baseline Assessments and Response Monitoring (2006) (34)
- A roadmap to safe, efficient, and stable lentivirus-mediated gene therapy with hematopoietic cell transplantation. (2007) (34)
- Cyclophosphamide, etoposide and G-CSF to mobilize peripheral blood stem cells for autologous stem cell transplantation in patients with lymphoma (2002) (34)
- Mesenchymal stromal cells as supportive cells for hepatocytes. (2009) (33)
- Donor hematopoietic cells from transgenic mice that express GFP are immunogenic in immunocompetent recipients (2005) (33)
- Hematopoiesis in the Elderly (2004) (33)
- Hierarchical organization of hematopoietic microenvironments: role of proteoglycans. (1988) (33)
- Cell-based therapies for osteonecrosis of the femoral head. (2008) (33)
- Feasibility and safety of autotransplants with noncryopreserved marrow or peripheral blood stem cells: a systematic review. (2006) (33)
- GM-CSF accelerates neutrophil recovery after autologous hematopoietic stem cell transplantation. (1996) (32)
- Facing the NIH funding crisis: how professional societies can help. (2012) (32)
- A phase I study of autologous bone marrow transplantation with stem cell gene marking in multiple myeloma. (1995) (32)
- Differential immunomodulatory effects of human bone marrow-derived mesenchymal stromal cells on natural killer cells. (2019) (32)
- Outcome of patients with transformed indolent non-Hodgkin lymphoma referred for autologous stem-cell transplantation. (2013) (32)
- A Phase I study of the transplantation of genetically marked autologous bone marrow stromal cells. (1998) (32)
- Lentivector Iterations and Pre-Clinical Scale-Up/Toxicity Testing: Targeting Mobilized CD34+ Cells for Correction of Fabry Disease (2017) (32)
- A retrospective observational study of leucoreductive strategies to manage patients with acute myeloid leukaemia presenting with hyperleucocytosis (2015) (32)
- Irradiated KHYG-1 retains cytotoxicity: Potential for adoptive immunotherapy with a natural killer cell line (2006) (32)
- Intensive therapy and autotransplant for patients with an incomplete response to front-line therapy for lymphoma. (1996) (31)
- Role of stromal cells and macrophages in fibronectin biosynthesis and matrix assembly in human long-term marrow cultures. (1993) (31)
- Acute leukemia occurring 19 years after treatment of acute lymphoblastic leukemia (1987) (31)
- High-dose chemotherapy and auto-SCT in elderly patients with Hodgkin's lymphoma (2011) (31)
- Do mesenchymal stromal cells transdifferentiate into functional cardiomyocytes? (2008) (31)
- Local radiotherapy induces homing of hematopoietic stem cells to the irradiated bone marrow. (2007) (31)
- Mesenchymal stromal cells as treatment for chronic GVHD (2011) (31)
- Electroporation for gene therapy. (1995) (30)
- Human long-term bone marrow culture. (1990) (30)
- Concise Review: TLR Pathway‐miRNA Interplay in Mesenchymal Stromal Cells: Regulatory Roles and Therapeutic Directions (2018) (30)
- Analysis of factors affecting hematopoietic recovery after autologous bone marrow transplantation for lymphoma. (1990) (30)
- Natural Killer Cells for Cancer Immunotherapy (2011) (29)
- Role of salvage radiation therapy for patients with relapsed or refractory hodgkin lymphoma who failed autologous stem cell transplant. (2012) (29)
- Peripheral neuropathy following high-dose etoposide and autologous bone marrow transplantation. (1994) (29)
- Overview of autologous stem cell transplantation. (2000) (28)
- Constitutively polarized granules prime KHYG-1 NK cells. (2006) (28)
- Successful pregnancy and delivery during α‐interferon therapy for chronic myeloid leukemia (1992) (27)
- Enhanced adaptive immunity in mice lacking the immunoinhibitory adaptor Hacs1 (2010) (27)
- Intensification of the stem cell transplant induction regimen results in increased treatment-related mortality without improved outcome in multiple myeloma (1999) (26)
- Retention of progenitor cell function in CD34+ cells purified using a novel O-sialoglycoprotease. (1992) (26)
- Male sexual function after autologous blood or marrow transplantation. (2001) (26)
- GVHD after unrelated cord blood transplant in children: characteristics, severity, risk factors and influence on outcome (2011) (25)
- Utility of subsequent conventional dose chemotherapy in relapsed/refractory transplant-eligible patients with diffuse large B-cell lymphoma failing platinum-based salvage chemotherapy (2008) (25)
- rbm47, a novel RNA binding protein, regulates zebrafish head development (2013) (25)
- Lack of Microsomal Prostaglandin E2 Synthase-1 in Bone Marrow–Derived Myeloid Cells Impairs Left Ventricular Function and Increases Mortality After Acute Myocardial Infarction (2012) (25)
- Results of Therapy for Acute Myeloid Leukemia in First Relapse. (1991) (23)
- Bead transfection: rapid and efficient gene transfer into marrow stromal and other adherent mammalian cells. (1993) (23)
- Incidence and risk factors for second cancers after autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma (2009) (23)
- Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in adults with acute lymphoblastic leukemia in first remission. (1998) (23)
- A phase II study of thalidomide and vinblastine for palliative patients with Hodgkin's lymphoma (2006) (22)
- New clonal karyotypic abnormalities acquired following autologous bone marrow transplantation for acute myeloid leukemia do not appear to confer an adverse prognosis (1998) (22)
- Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation. (1993) (21)
- An adult uterine hemangioblast: evidence for extramedullary self-renewal and clonal bilineage potential. (2010) (21)
- Second-line salvage chemotherapy for transplant-eligible patients with Hodgkin’s lymphoma resistant to platinum-containing first-line salvage chemotherapy (2012) (21)
- Overcoming Challenges to Initiating Cell Therapy Clinical Trials in Rapidly Developing Countries: India as a Model (2013) (21)
- Non-Myeloablative Hematopoietic Stem Cell Transplantation in Older Patients with AML and MDS: Results from the Center for International Blood and Marrow Transplant Research (CIBMTR) (2008) (21)
- Biomarkers of potential prognostic significance in diffuse large B‐cell lymphoma (2006) (21)
- Neutrophilic myelofibrosis presenting as philadelphia chromosome negative BCR non‐rearranged chronic myeloid leukemia (1990) (20)
- Group V Phospholipase A2 in Bone Marrow-derived Myeloid Cells and Bronchial Epithelial Cells Promotes Bacterial Clearance after Escherichia coli Pneumonia* (2011) (20)
- Donor stem cells home to marrow efficiently and contribute to short- and long-term hematopoiesis after low-cell-dose unconditioned bone marrow transplantation. (2002) (20)
- Pretransplantation consolidation chemotherapy decreases leukemia relapse after autologous blood and bone marrow transplants for acute myelogenous leukemia in first remission. (2006) (20)
- Influence of total body irradiation on infections after autologous bone marrow transplantation. (1991) (20)
- Autologous Bone Marrow Transplantation for Acute Myeloid Leukemia (1996) (19)
- Sca-1+Lin−CD117− Mesenchymal Stem/Stromal Cells Induce the Generation of Novel IRF8-Controlled Regulatory Dendritic Cells through Notch–RBP-J Signaling (2015) (18)
- A radiolabeled antibody targeting CD123+ leukemia stem cells – initial radioimmunotherapy studies in NOD/SCID mice engrafted with primary human AML (2015) (18)
- Combining gene mutation with gene expression analysis improves outcomes prediction in acute promyelocytic leukemia. (2019) (18)
- GM-CSF therapy for delayed engraftment after autologous bone marrow transplantation. (1991) (18)
- Human mesenchymal stromal cells improve scar thickness without enhancing cardiac function in a chronic ischaemic heart failure model. (2012) (18)
- Mesenchymal stromal cells improve cardiac function and left ventricular remodeling in a heart transplantation model. (2015) (18)
- Correlation between cytogenetic and molecular findings in human chronic myelogenous leukemia lines EM-2 and EM-3. (1987) (18)
- Different response to salvage chemotherapy but similar post-transplant outcomes in patients with relapsed and refractory Hodgkin’s lymphoma (2010) (18)
- Bone Marrow Therapies for Chronic Heart Disease (2015) (18)
- An evaluation of outpatient bone marrow harvesting. (1989) (18)
- CD16+NK-92 and anti-CD123 monoclonal antibody prolongs survival in primary human acute myeloid leukemia xenografted mice (2018) (17)
- Concise review: Bone marrow autotransplants for liver disease? (2013) (17)
- Donor Mesenchymal Stromal Cells (MSCs) Undergo Variable Cardiac Reprogramming in Vivo and Predominantly Co-Express Cardiac and Stromal Determinants after Experimental Acute Myocardial Infarction (2014) (17)
- Mesenchymal Stromal Cells in Regenerative Medicine: A Perspective (2013) (16)
- Cell Therapy for Age-Related Disorders: Myocardial Infarction and Stroke – A Mini-Review (2008) (16)
- Maintenance of Philadelphia-chromosome-positive progenitors in long-term marrow cultures from patients with advanced chronic myeloid leukemia. (1992) (16)
- Advances in targeted therapy for chronic myeloid leukemia (2003) (15)
- Ph positive CML cell lines. (1987) (15)
- NTAL is associated with treatment outcome, cell proliferation and differentiation in acute promyelocytic leukemia (2020) (15)
- Cell Therapy for Knee Osteoarthritis: Mesenchymal Stromal Cells (2019) (15)
- Tissue‐specific activity of heterologous viral promoters in primary rat hepatocytes and Hep G2 cells (1989) (15)
- Analysis of the microenvironment necessary for engraftment: role of the vascular smooth muscle-like stromal cells. (2000) (15)
- Chronic myeloid leukemia arising in a progenitor common to T cells and myeloid cells. (1990) (14)
- de Doxorubicin-Conjugated Immuno-Nanoparticles for Intracellular Anticancer Drug Delivery P E R (2009) (14)
- The hematopoietic stem cell in elderly patients with leukemia. (1996) (14)
- 9: Allogeneic hematopoietic stem cell transplantation in HIV-positive patients with malignant and non-malignant disorders: A report from the center for international blood and marrow transplant research (CIBMTR) (2007) (14)
- Granulocyte–macrophage colony-stimulating factor-associated histiocytosis and capillary-leak syndrome following autologous bone marrow transplantation: two case reports and a review of the literature (1998) (14)
- Bone marrow mononuclear cell count does not predict neutrophil and platelet recovery following autologous bone marrow transplant: value of the colony-forming unit granulocyte-macrophage (CFU-GM) assay. (1997) (14)
- Banking Mesenchymal Stromal Cells from Umbilical Cord Tissue: Large Sample Size Analysis Reveals Consistency Between Donors (2019) (14)
- Clonogenic assays measure leukemia stem cell killing not detectable by chromium release and flow cytometric cytotoxicity assays. (2010) (14)
- Therapeutic properties of mesenchymal stem cells for autism spectrum disorders. (2015) (14)
- Long-term outcome after intensive therapy with etoposide, melphalan, total body irradiation and autotransplant for acute myeloid leukemia (2004) (14)
- Depletion of bone marrow CCSP-expressing cells delays airway regeneration. (2015) (14)
- Is there a role for autotransplants in AML in first remission? (2009) (14)
- Mesenchymal stromal cell therapy to promote cardiac tissue regeneration and repair (2016) (13)
- Synergistic effect of ketoconazole and antineoplastic agents on hormone-independent prostatic cancer cells. (1989) (13)
- Primary yolk sac (endodermal sinus) tumor of the prostate: Case report and review of the literature (1990) (13)
- Humanized anti-CD123 antibody facilitates NK cell antibody-dependent cell-mediated cytotoxicity (ADCC) of Hodgkin lymphoma targets via ARF6/PLD-1 (2019) (13)
- Rapid isolation of bone marrow mesenchymal stromal cells using integrated centrifuge-based technology. (2016) (13)
- T Cell Repertoire Evolution after Allogeneic Bone Marrow Transplantation: An Organizational Perspective. (2019) (13)
- Treatment response and overall outcome of patients with relapsed and refractory peripheral T-cell lymphoma compared to diffuse large B-cell lymphoma (2013) (13)
- Prodrugs and prodrug-activated systems in gene therapy (2021) (13)
- Gene therapy with physical methods of gene transfer. (1996) (12)
- Bone Marrow Transplantation for Acute Myelogenous Leukemia (1997) (12)
- CD25 Blockade Delays Regulatory T Cell Reconstitution and Does Not Prevent Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation. (2017) (12)
- MicroSPECT/CT imaging of primary human AML engrafted into the bone marrow and spleen of NOD/SCID mice using 111In-DTPA-NLS-CSL360 radioimmunoconjugates recognizing the CD123+ / CD131- epitope expressed by leukemia stem cells. (2014) (12)
- Hydrogen Peroxide-Induced Senescence Reduces the Wound Healing-Promoting Effects of Mesenchymal Stem Cell-Derived Exosomes Partially via miR-146a (2021) (12)
- OCT4 expression mediates partial cardiomyocyte reprogramming of mesenchymal stromal cells (2017) (11)
- Flow cytometric assessment of autologous gammadelta T cells in patients with acute myeloid leukemia: potential effector cells for immunotherapy? (2006) (11)
- Acute leukemia in adults (1995) (11)
- Studies on the in vitro microenvironment in man. (1983) (11)
- Older patients with acute myeloid leukemia (2010) (11)
- Allogeneic Hematopoietic Stem Cell Transplantation in HIV-Positive Patients with Malignant and Non-Malignant Disorders: A Report from the Center for International Blood and Marrow Transplant Research (CIBMTR). (2006) (11)
- Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in chronic myelogenous leukemia in chronic phase. (1999) (11)
- Flow cytometric assessment of autologous γδ T cells in patients with acute myeloid leukemia: Potential effector cells for immunotherapy? (2006) (11)
- Human gene therapy. (1997) (11)
- Human long-term bone marrow culture. (1997) (11)
- Generation of Functional Hepatocytes from Human Adipose‐Derived MYC+ KLF4+ GMNN+ Stem Cells Analyzed by Single‐Cell RNA‐Seq Profiling (2018) (10)
- Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in adults with acute myelogenous leukemia in 1st remission. (1999) (10)
- The v-raf oncogene enhances tumorigenicity and suppresses differentiation in vivo in a rat hepatocyte cell line. (1993) (10)
- ‘Relative’ chemotherapy sensitivity: the impact of number of salvage regimens prior to autologous stem cell transplant for relapsed and refractory aggressive non-Hodgkin's lymphoma (2002) (10)
- The c-abl, bcr and C lambda genes are amplified in a cell line but not in the uncultured cells from a patient with chronic myelogenous leukemia. (1986) (10)
- Investigation of bcr‐abl transcription by ph‐positive chronic myeloid leukemia progenitors (1993) (9)
- Molecular approaches to the detection and monitoring of chronic myeloid leukemia: theory and practice. (1999) (9)
- ras transformation of simian virus 40-immortalized rat hepatocytes: an in vitro model of hepatocarcinogenesis. (1992) (9)
- Pleural effusions in patients treated with dasatinib: Results from two institutions, risk factors and management (2007) (9)
- Humanized Chronic Graft-versus-Host Disease in NOD-SCID il2rγ-/- (NSG) Mice with G-CSF-Mobilized Peripheral Blood Mononuclear Cells following Cyclophosphamide and Total Body Irradiation (2015) (9)
- Synergistic effect of stem cell factor with interleukin-3 or granulocyte-macrophage colony-stimulating factor on the proliferation of murine primitive hematopoietic progenitors. (1994) (9)
- Reduced SLIT2 is Associated with Increased Cell Proliferation and Arsenic Trioxide Resistance in Acute Promyelocytic Leukemia (2020) (9)
- FACTs Fabry gene therapy clinical trial: Two-year data (2019) (9)
- Outcome of Patients with Relapsed or Refractory Non-Hodgkin's Lymphoma Referred for Autologous Bone Marrow Transplantation. (1991) (9)
- Chronic myeloid leukemia: current therapies and the potential role of farnesyltransferase inhibitors. (2002) (9)
- Bone Marrow Mononuclear Cell Count does not Predict Neutrophil and Platelet Recovery following Autologous Bone Marrow Transplant: Value of the Colony-Forming Unit Granulocyte-Macrophage (CFU-GM) Assay (1997) (8)
- Blood stem cell collection: factors influencing the recovery of granulocyte-macrophage colony forming cells. (1996) (8)
- A Randomized Trial Of Rituximab Vs Observation Following Autologous Stem Cell Transplantation (ASCT) For Relapsed Or Refractory CD20-Positive B Cell Lymphoma: Final Results Of NCIC CTG LY.12 (2013) (8)
- Adult Acute Lymphoblastic Leukaemia: The Value of Therapy Intensification. (1991) (8)
- Successful pregnancy and delivery during alpha-interferon therapy for chronic myeloid leukemia. (1992) (8)
- In vitro clonal culture of human hematopoietic progenitor cells. (1990) (8)
- Management of Hyperleukocytosis in Acute Myelogenous Leukemia Using Hydroxyurea Rather Than Leukopheresis. (2006) (8)
- Killer Immunoglobulin-like Receptor-Ligand Interactions Predict Clinical Outcomes Following Unrelated Donor Transplants (2019) (8)
- G-CSF-stimulated BM progenitor cells supplement suboptimal peripheral blood hematopoietic progenitor cell collections for auto transplantation (2008) (7)
- What We Have Learned and What We Need to Know (2006) (7)
- Ciprofloxacin‐induced neutropenia and erythema multiforme (1993) (7)
- The principles and overview of autologous hematopoietic stem cell transplantation. (2009) (7)
- The relationship between absolute lymphocyte count with PFS in patients with Hodgkin's lymphoma undergoing autologous hematopoietic cell transplant (2008) (7)
- High dose etoposide melphalan, total body irradiation and ABMT for acute myeloid leukemia in first remission. (1992) (7)
- Human Mesenchymal Stromal Cells Improve Cardiac Perfusion in an Ovine Immunocompetent Animal Model (2016) (7)
- The conditional survival analysis of relapsed DLBCL after autologous transplant: a subgroup analysis of LY.12 and CORAL. (2020) (7)
- A phase I study of interleukin-6 after autologous bone marrow transplantation for patients with poor prognosis Hodgkin's disease. (1997) (7)
- Preparing for the Unthinkable: Emergency Preparedness for the Hematopoietic Cell Transplant Program (2006) (7)
- The Hematopoietic Microenvironment (2000) (7)
- Immunophenotypic Characterization and Therapeutics Effects of Human Bone Marrow- and Umbilical Cord-derived Mesenchymal Stromal Cells in an Experimental Model of Sepsis. (2021) (7)
- W/Wv marrow stromal cells engraft and enhance early erythropoietic progenitors in unconditioned Sl/Sld murine recipients (2002) (7)
- Topical Application of Culture‐Expanded CD34+ Umbilical Cord Blood Cells from Frozen Units Accelerates Healing of Diabetic Skin Wounds in Mice (2018) (6)
- Corrigendum: Harmonizing standards for producing clinical-grade therapies from pluripotent stem cells (2014) (6)
- Outcomes of Salvage Chemotherapy and Autologous Stem Cell Transplantation for Relapsed or Refractory Primary Mediastinal Large B Cell Lymphoma (PMLCL) Are Inferior to Diffuse Large B Cell Lymphoma (DLBCL). (2005) (6)
- When the best is the enemy of the good: the case of bone-marrow mononuclear cells to treat ischemic syndromes (2013) (6)
- Abstract 2302: An ‘off the shelf,’ GMP-grade, IL-2-independent NK cell line expressing the high-affinity Fc-receptor to augment antibody therapeutics (2016) (5)
- The use of GM-CSF as an adjunct to autologous/syngeneic bone marrow transplantation: a prospective randomized controlled trial. (1991) (5)
- Uterine-derived stem cells reconstitute the bone marrow of irradiated mice. (2015) (5)
- Safety of therapeutic anticoagulation in patients with multiple myeloma receiving autologous stem cell transplantation (1998) (5)
- Phase I/II trial of cyclophosphamide, mitoxantrone, and escalated doses of carboplatin supported by peripheral-blood stem cells in women with metastatic breast cancer. (2000) (5)
- Acute leukemia in adults (1996) (5)
- Impact of Cytogenetics on Outcome of Mismatched Unrelated Donor Hematopoietic Stem Cell Transplantation for Adults with AML. (2004) (5)
- Photodynamic elimination of clonogenic Ph+ chronic myeloid leukemia cells. (1993) (5)
- Bone marrow cells for cardiac repair. (2005) (5)
- Hematopoietic cytokines enhance survival of SCID mice undergoing high-dose irradiation. (1994) (5)
- Characterization of Bone Marrow Stromal Cells. (1999) (5)
- Enhancing research in regenerative medicine. (2010) (5)
- Missplicing of Glycogen Synthase Kinase 3β: A Potential Mechanism of Blast Crisis Chronic Myeloid Leukemia Stem Cell Generation. (2007) (4)
- Outpatient bone marrow harvesting: an update. (1995) (4)
- T-Cell Blast Crisis in Chronic Myeloid Leukemia. (1991) (4)
- Addition of Rituximab to CHOP Is an Attractive Strategy as Primary Therapy for Diffuse Large B Cell Lymphoma (DLBCL) in Patients Age <60 Years: An Economic Analysis. (2004) (4)
- Allogeneic hematopoietic cell transplants for thalassemia (2017) (4)
- Acute transient parotitis after high dose etoposide and autologous bone marrow transplantation. (1990) (4)
- Immunoreactive parathyroid hormone and in vitro inhibition of erythropoiesis by uremic serum in patients on continuous ambulatory peritoneal dialysis. (1986) (4)
- Overcoming the challenges of conducting translational research in cell therapy (2011) (4)
- Acute Promyelocytic Leukemia: A Case-based Review (2003) (4)
- Second Cancers after Autologous Hematopoietic Stem Cell Transplantation (ASCT) for Relapsed/Refractory Aggressive Non-Hodgkin’s Lymphoma (NHL). (2007) (4)
- The autologous blood and marrow transplant long-term follow-up clinic: a model of care for following and treating survivors of autotransplant (2002) (4)
- Regenerative and cell therapy : clinical advances (2004) (3)
- Similar 5-Year Survival after Peripheral Blood Autotransplants (AutoPB) Versus HLA Matched Sibling Myeloablative Transplants (AlloBMT) for Acute Myeloid Leukemia (AML) in First Complete Remission (CR1). (2008) (3)
- Culture Conditions for Generating Human Bone Marrow Stromal Cells Influence Cell Immunophenotype and In Vivo Biodistribution in Immune Deficient Mice. (2004) (3)
- Gamma Delta T Cells (GDTCs) to Eliminate Minimal Residual Disease (MRD) in Chronic Myeloid Leukemia (CML) : A Pre-Clinical Model (2008) (3)
- Pancreatic cancer growth promoted by bone marrow mesenchymal stromal cell-derived IL-6 is reversed predominantly by IL-6 blockade. (2022) (3)
- Reaching beyond maximum grade: progress and future directions for modernising the assessment and reporting of adverse events in haematological malignancies. (2022) (3)
- Stem Cells: Umbilical Cord/Wharton’s Jelly Derived (2020) (2)
- Regenerative and Cell Therapy (2005) (2)
- NK-92 Preferentially Targets Acute Myeloid Leukemia Stem Cells (2010) (2)
- A brief history of hematopoietic cell transplantation (2017) (2)
- Beyond bone marrow: a new source of stem cells. (2001) (2)
- Ex Vivo Stromal Cell Electroporation of Factor IX cDNA for Treatment of Hemophilia B. (2000) (2)
- Prolonged Disease-Free Survival in an Adult Presenting with Burkitt-Type Acute Lymphoblastic Leukaemia and CNS Disease (1992) (2)
- Event-Free Survival As a Surrogate for Overall Survival in Relapsed DLBCL after Autologous Transplant: A Subgroup Analysis of LY.12 and Coral (2019) (2)
- Bone marrow stromal cell transplantation (1995) (2)
- Bioluminescent Imaging of Human Leukemic Stem Cell Engraftment. (2005) (2)
- Clinical significance of mitochondrial DNA content in acute promyelocytic leukaemia (2021) (2)
- Adhesion of Hematopoietic Precursors to Human Stroma: Studies Using Normal Marrow Stromal Myofibroblasts and a Stromal Cell Line Transformed by SV40. (1998) (2)
- Expression of Factor IX cDNA Introduced into Human Marrow Stromal Cells by Electroporation. (1998) (2)
- Mesenchymal Stromal Cells: Latest Advances (2011) (2)
- GDP (Gemcitabine, Dexamethasone, Cisplatin) Salvage Therapy Results in Superior Progression Free Survival Compared to Mini-Beam Prior to Autologous Stem Cell Transplantation for Relapsed or Refractory Hodgkin’s Lymphoma. (2004) (2)
- NK-92 Therapy Is Well Tolerated, Has Minimal Toxicity and Shows Efficacy in a Phase I Trial of Patients with Relapsed/Refractory Hematological Malignancies Relapsing after Autologous Stem Cell Transplantation (2015) (2)
- Hematopoietic Cell Transplants: Concepts, Controversies, and Future Directions (2017) (2)
- Development and characterization of a new inbred transgenic rat strain expressing DsRed monomeric fluorescent protein (2014) (2)
- Studies of the in vitro microenvironment in human long-term marrow cultures. (1984) (2)
- Emerging Therapies for Chronic GVHD (2002) (2)
- NK-92 Cytotoxicity Against Cancer Stem Cells in Hematologic Malignancies (2013) (2)
- Prolonged engraftment and transgene expression of genetically modified autologous bone marrow stromal (mesenchymal) cells after infusion post autotransplant: A platform for cell and gene therapy. (2001) (2)
- Predictive value of karyotype on outcome of autotransplants for acute myeloid leukemia in second remission (2005) (2)
- Meeting Report: Mesenchymal and nonhematopoietic stem cells: recent progress and current controversies (2001) (1)
- The effect of local breast radiotherapy on circulating CD34(+) cells. (2011) (1)
- Human autologous mesenchymal stromal cells for the treatment of mid- to late-stage knee osteoarthritis—preliminary results from a first-in-North America phase I/II study (2017) (1)
- Current Treatment of Chronic Myeloid Leukemia (2001) (1)
- Acute leukemia: diagnosis, management, and potential for cure. (1988) (1)
- Concluding Annotation to Torensma et al. (2000) (1)
- Febrile neutropenia after hematopoietic stem cell mobilization with chemotherapy and G-CSF does not affect collection of adequate numbers of CD34+ cells. (1997) (1)
- Autologous stem cell transplantation (ASCT) for relapsed/refractory follicular large cell lymphoma (FLCL). (2002) (1)
- Risk of Acute Leukemia Post-Autologous Stem Cell Tranplant (ASCT) for Hodgkin’s Lymphoma (HL) Depends on Choice of Salvage Chemotherapy and Use of Radiation. (2007) (1)
- Stem Cell Dose and Time To Engraftment Does Not Predict Outcome After Autologous Stem Cell Transplantation For Relapsed Aggressive NHL (2013) (1)
- Mesenchymal Stromal Cells (MSCs) Acquire Cardiac-Specific Markers but Do Not Become Functional Cardiomyocytes and Retain the Stromal Phenotype. (2007) (1)
- Hematopoietic cytokines enhance survival of SCID mice undergoing high-dose irradiation. (1994) (1)
- Increased donor inhibitory KIR with known HLA interactions provide protection from relapse following HLA matched unrelated donor HCT for AML (2021) (1)
- Chronic graft-versus-host disease: Consensus, challenges, and controversies (2017) (1)
- Efficacy and safety of stem cell mobilization following gemcitabine, dexamethasone, cisplatin (GDP) salvage chemotherapy in patients with relapsed or refractory lymphoma (2020) (1)
- Abstract 2043: Bone Marrow Mesenchymal Stem Cells Acquire a Cardiogenic Phenotype via Transdifferentiation and Cell Fusion with Cardiomyocytes (2006) (1)
- Hodgkin-Lymphoma with Relapsed or Progressive Disease after Autologous Stem Cell Transplantation: Efficacy of Salvage Radiation Therapy (2009) (1)
- Short and Long Term Efficacy of Autologous Bone Marrow Cells To Support Intensive Chemotherapy in Patients Failing Peripheral Blood Stem Cell Mobilization. (2007) (1)
- NK Cell Line Killing of Leukemia Cells Is Enhanced By Reverse Antibody Dependent Cell Mediated Cytotoxicity (R-ADCC) Via NKp30 and NKp44 and Target Fcγ Receptor II (CD32) (2014) (1)
- Human ascites does not affect NK-92 cytotoxicity and intraperitoneal compared with intravenous administration of NK-92 shows superior survival in human ovarian cancer xenografted mice (2018) (1)
- Anticancer Drug Delivery: Doxorubicin‐Conjugated Immuno‐Nanoparticles for Intracellular Anticancer Drug Delivery (Adv. Funct. Mater. 11/2009) (2009) (1)
- Human mesenchymal stromal cells do not promote recurrence of soft tissue sarcomas in mouse xenografts after radiation and surgery. (2018) (1)
- Introductory Commentary on The Role of Stromal Integrin Interactions in Pro-B-Cell Proliferation Hahn et al (2000) (1)
- Severe hepatotoxicity from granulocyte-macrophage colony-stimulating factor administered after autologous bone marrow transplantation. (1995) (1)
- In vitro clonal culture of human hematopoietic progenitor cells. (1997) (1)
- Activation of c-kit Is Necessary for Mobilization of Reparative Bone Marrow Progenitor Cells in Response to Ischemic Cardiac Injury (2004) (1)
- The nomenclature of mesenchymal stem cells and mesenchymal stromal cells (2016) (1)
- A Phase II Study of Peripheral Blood Stem Cell (PBSC) Mobilization Using Stem Cell Factor (SCF), Filgrastin (G-CSF), and Cyclophosphamide (CY) in Patients at High Risk for Mobilization Failure. (2004) (1)
- The Anti-CD25 Antibody Daclizumab Delays Treg Reconstitution, Promotes CD4 Memory, and Does Not Prevent Acute or Chronic Gvhd After Allogeneic Stem Cell Transplantation (2012) (1)
- Gene therapy for Fabry disease patients: The importance of efficient biomarker monitoring (2013) (1)
- Acute myeloid leukemia Long-term outcome after intensive therapy with etoposide, melphalan, total body irradiation and autotransplant for acute myeloid leukemia (2004) (1)
- Hematopoietic cell transplantation: Is there any age limit? (2017) (1)
- Hematopoietic cell transplants for T-cell lymphomas (2017) (1)
- Treatment of acute myeloid leukemia (AML) at diagnosis in 99 unselected adults with high dose ARA-C (HIDAC) and mitoxantrone: Long-term follow-up. (1996) (1)
- Autotransplants for germ cell tumor: How best to do it (2017) (1)
- Outcome of salvage therapy for relapsed or refractory peripheral T-cell lymphoma (PTCL), anaplastic large cell lymphoma (ALCL), and diffuse large B-cell lymphoma (DLBCL). (2006) (1)
- American Society for Blood and Marrow Transplantation guidelines for training. (2001) (1)
- Concluding Annotation to Armeanu et al. (2000) (1)
- Abstract 1478: Angiogenesis After a Myocardial Infarction is Regulated by Bone Marrow c-kit+ Cells (2006) (1)
- Immune therapy with cytotoxic T-lymphocytes for treatment of infections (2017) (0)
- syndrome and acute myeloid leukemia Allogeneic transplantation for therapy-related myelodysplastic (2011) (0)
- Organ-specific complications after hematopoietic cell transplants: Practical considerations and controversies (2017) (0)
- Predictors of Mortality in Patients Undergoing Autologous Stem Cell Transplant (ASCT) Admitted to the Intensive Care Unit: An Institutional Review of 1013 Transplant Patients over Five Years. (2007) (0)
- Autologous hematopoietic cell transplants for plasma cell myeloma: One, two, or none? (2017) (0)
- Correction: Increased donor inhibitory KIR with known HLA interactions provide protection from relapse following HLA matched unrelated donor HCT for AML (2021) (0)
- Donor-specific anti-human leukocyte antigen antibodies and risk of graft failure after hematopoietic cell transplants (2017) (0)
- NK cells for cancers (2017) (0)
- Allogeneic Stem Cell Transplantation (AlloSCT) for the Treatment of Therapy-Related Myelodysplastic Syndrome (tMDS) and Acute Myeloid Leukemia (tAML): Results from the Center for International Blood and Marrow Transplant Research (CIBMTR). (2007) (0)
- Clinical significance of clonal hematopoiesis in the setting of autologous stem cell transplantation for lymphoma (2021) (0)
- Selecting human leukocyte antigen haplotype mismatch versus cord blood graft (2017) (0)
- of Ia (HLA-DR) positive cells The generation of human long-term marrow cultures from marrow depleted (2011) (0)
- Identifying Mechanisms of Enhanced NK Cell Cytotoxicity Using Permanent NK Cell Lines. (2004) (0)
- Persistent hematopoietic polyclonality after lentivirus-mediated gene therapy for Fabry disease (2023) (0)
- Autologous hematopoietic cell transplants for autoimmune diseases: Specific diseases and controversies (2017) (0)
- Concluding Annotation to Hahn et al (2000) (0)
- Quality of life: Can we really make a difference? (2017) (0)
- Keystone Symposium: The Hematopoietic Microenvironment (1996) (0)
- Faculty Opinions recommendation of Human acute myeloid leukemia CD34+CD38- stem cells are susceptible to allorecognition and lysis by single KIR-expressing natural killer cells. (2010) (0)
- Genetic Disruption of □pdl and □pdlr Phospholipases in Mice Leads to Impaired Platelet Adhesion and Aggregation (2008) (0)
- Pharmacologic controversies in hematopoietic cell transplants (2017) (0)
- John M. Goldman, DM (1938-2013) (2014) (0)
- Potential anti-inflammatory mechanism of action of mesenchymal stromal cells in osteoarthritis patients results in overall improvement in pain and symptoms (2018) (0)
- Treatment of COVID-19 with MSCs: how does it work? (2021) (0)
- Hematopoietic cell transplants for Fanconi anemia (2017) (0)
- Subject Index, Vol. 6, 1986 (1986) (0)
- Allogeneic hematopoietic cell transplants for sickle cell disease (2017) (0)
- Evaluating new therapy for acute myeloid leukemia. (1991) (0)
- Outcome following multiple lines of salvage chemotherapy prior to autologous stem cell transplant for relapsed or refractory diffuse large B-cell lymphoma (DLBCL) (2007) (0)
- Towards a clinical trial of lentivirus-mediated gene therapy for Fabry disease: In vitro patient cell mobilization and transduction outcomes (2014) (0)
- Prospective Clinical Trials in BMT Come of Age in the US: The Blood and Marrow Transplant Clinical Trials Network (2007) (0)
- Enhancing Research in Regenerative Medicine (2011) (0)
- CD34+ cell mobilization in autologous and allogeneic hematopoietic cell transplants (2017) (0)
- Clinical and Functional Studies Reveal That TP73 Isoforms Levels Are Associated with Prognosis and RA-Resistance in Acute Promyelocytic Leukemia (2019) (0)
- THE INFUSION OF MESENCHYMAL STROMAL CELLS INCREASES MYOCARDIAL S100A6 AND LIMITS ADVERSE LEFT VENTRICULAR REMODELING POST MYOCARDIAL INFARCTION (2014) (0)
- Highlights of the Fifth International Symposium on Autologous Bone Marrow Transplantation Omaha, Nebraska, August 23-25, 1990. (1991) (0)
- Outcomes of salvage chemotherapy and autologous transplantation for large cell transformation of follicular lymphoma—A comparison of outcomes with relapsed/refractory diffuse large B cell lymphoma (2006) (0)
- Stromal Cell Types: Characterization and Function In Situ and In Vitro. (1999) (0)
- Blood and marrow transplant organizations (2009) (0)
- Maintenance therapy in plasma cell myeloma after autologous transplant (2017) (0)
- Outcomes of Second-Line Chemotherapy and Autologous Stem Cell Transplantation for Primary Refractory Diffuse Large B Cell Lymphoma (2008) (0)
- Salvage Chemotherapy Hodgkin's Disease and for Non-Hodgkin's Lymphoma (1991) (0)
- HUMAN BONE MARROW MESENCHYMAL STROMAL CELLS DO NOT INCREASE LOCAL RECURRENCE OF HUMAN SOFT TISSUE SARCOMAS IN MICE XENOGRAFT MODELS AFTER RADIOTHERAPY AND SURGERY (2012) (0)
- Simian Virus 40Transformed 40Transformed 40Transformed Adherent Cells From Human Long-term Marrow Cultures : Cloned Cell Lines Produce Cells With Stromal and Hematopoietic Characteristics (2005) (0)
- Abstract 15610: The Infusion of Mesenchymal Stromal Cells Post Myocardial Infarction Increases Myocardial S100A6, Attenuates Myocyte Hypertrophy, Reduces Myocyte Apoptosis and Improves Cardiac Function (2014) (0)
- Considerations of Quality Control Issues for the Mesenchymal Stem Cells-Based Medicinal Products (2013) (0)
- Towards the repair of marginal liver grafts: Mesenchymal stromal cell therapy. (2018) (0)
- Hematopoietic cell transplants for mantle cell lymphoma (2017) (0)
- Exosomes secreted by mesenchymal stromal/stem cell-derived adipocytes promote breast cancer cell growth via activation of Hippo signaling pathway (2019) (0)
- The Recruitment and Retention of Hematologists: We Want Your Input (2012) (0)
- A multicentre study of granulocyte-macrophage colony stimulating factor (GM-CSF) in combination with consolidation therapy in adult acute myeloid leukemia (AML). (1996) (0)
- Low incidence of myelodysplasia (MDS) or acute leukemia (AML) after autologous blood or marrow transplant without total body radiation (TBI) for lymphoma (1997) (0)
- Effect of gemcitabine, dexamethasone and cisplatin salvage chemotherapy (GDP) on peripheral blood stem cell (PBSC) mobilization in patients with lymphoma. (2002) (0)
- TLR3 or TLR4 Activation Enhances MSC-Mediated Treg Generation Via Notch Signaling (2015) (0)
- Hematopoietic cell transplants for chronic myeloid leukemia: Still a role for allogeneic transplant? (2017) (0)
- Allogeneic hematopoietic cell transplants for plasma cell myeloma (2017) (0)
- Helping to shape drug shortage provision in FDA user fee legislation. (2012) (0)
- Strategies to augment graft-versus-leukemia and -lymphoma effects (2017) (0)
- Progress treating acute graft-versus-host disease? (2017) (0)
- Autologous Gamma-Delta T (GD-T) Cells in Acute Myeloid Leukemia (AML): Potential Immune Effector Cells for Minimal Disease?. (2004) (0)
- Sensory Neuropeptides Prime the Splenic Marginal Zone for Optimal Humoral Immunity (2014) (0)
- Human Autologous Mesenchymal Stromal Cells for the Treatment of Mid to Late Stage Knee Osteoarthritis—A Phase I Pilot Study (2016) (0)
- ASH Announces $ 9 Million Bridge Grant Program to Combat the Reduction in NIH Funding Commits to 30 one-year grants (0)
- Highlights of the 19th Annual Meeting of the International Society for Experimental Hematology (ISEH) Held in Seattle, Washington, USA, August 26-30, 1990. (1991) (0)
- Hematopoietic cell transplantation for immunoglobulin light chain (AL) amyloidosis (2017) (0)
- Expanded umbilical cord cells: Benefits and limitations (2017) (0)
- Dr. Ernest McCulloch. (2011) (0)
- Concluding Annotation to Ploemacher et al (2000) (0)
- Preventing relapse post-transplant: When and how to best intervene? (2017) (0)
- Introductory Commentary on Regulation of LFA-1 Expression by CD34+ Cells and Inducible Growth Factor Production by Stroma Enable Formation of Bone Marrow Compartments, Torensma et al. (2000) (0)
- 79 Thoracic radiation therapy (RT) before autologous bone marrow transplantation (ABMT) in relapsed or refractory Hodgkin's disease (HD) (1997) (0)
- Introductory Commentary on Gap Junction Intercellular Communication is Likely to be Involved in Regulation of Stroma-dependent Proliferation of Hematopoietic Stem Cells Ploemacher R. Et Al (2000) (0)
- Febrile neutropenia does not affect collection of adequate cd34+ cells after mobilization with chemotherapy and g-csf (1997) (0)
- Immune paralysis and reconstitution after hematopoietic cell transplants (2017) (0)
- Matrix Metalloproteinases. (1999) (0)
- Blood Stem Cell Collection: Factors Influencing the Recovery of Granulocyte-Macrophage Colony Forming Cells (1996) (0)
- Autologous hematopoietic cell transplants for autoimmune diseases: Therapeutic rationale and limitations (2017) (0)
- Human leukocyte antigen-haplotype mismatch transplants: Overcoming major genetic barriers (2017) (0)
- Establishment of Xenogeneic Lung Chronic Graft-Verus-Host Disease Mice Model (2014) (0)
- lymphoblastic leukemia in first complete remission Unrelated donor transplants in adults with Philadelphia-negative acute (2011) (0)
- Towards the repair of marginal liver grafts: Ex vivo Mesenchymal stromal cell perfusion (2016) (0)
- Gene therapy in hematopoietic cell transplants (2017) (0)
- Hematopoietic cell transplants for Hodgkin lymphoma (2017) (0)
- Introductory Commentary on Involvement of E-Cadherin in the Development of Erythroid Cells, Armeanu et al. (2000) (0)
- Superior Cytotoxicity of Clonal Versus Polyclonal Gamma Delta T Cells against Philadelphia Chromosome Positive and B-CLL Derived Leukemic Cells. (2009) (0)
- characteristics cultures: cloned cell lines produce cells with stromal and hematopoietic Simian virus 40-transformed adherent cells from human long-term marrow (2011) (0)
- Post-transplant relapse and graft failure: Does a second allogeneic hematopoietic cell transplant work? (2017) (0)
- CD34+ cell selection: Current concepts, methods, and controversies (2017) (0)
- Gene Transfer by Electroporation (1989) (0)
- Response from R.W. Tsang, et al. (1999) (0)
- Prevention of acute graft-versus-host disease – one size fits all? (2017) (0)
- New perspectives in manufacturing hematopoietic cells (2017) (0)
- Culturing Lymphocytes in Simulated Microgravity using a Rotary Cell Culture System. (2022) (0)
- Hematopoietic cell transplants for acute myeloid leukemia: Is there a best approach? (2017) (0)
- Hematopoietic growth factors after hematopoietic cell transplantation: Are they useful? (2017) (0)
- Infused marrow stromal cells lodged in damaged myocardium exhibit a phenotype with stromal and cardiomyocyte markers (2008) (0)
- Epstein_Barr virus-driven lymphoproliferation: Surveillance and therapy (2017) (0)
- Inferior Progression-Free Survival after Autotransplant for Relapsed or Refractory Aggressive Non-Hodgkin’s Lymphoma in Patients > 60 Versus ≤ 60 Years of Age. (2006) (0)
- Autologous bone marrow transplantation. (1986) (0)
- Peripheral Blood Stem Cell Harvests Performed Beyond the Initial Two Days of Apheresis May Not Contribute to Accelerate Granulocyte and Platelet Engraftment After Autologous Stem Cell Transplantation. (2009) (0)
- Arsenic Trioxide Abrogate MN1 Mediated RA-Resistance in Acute Promyelocytic Leukemia (2019) (0)
- Autotransplants f or H odgkin's D isease i n P atients N ever Achieving R emission: A R eport F rom t he A utologous B lood and M arrow T ransplant R egistry (2011) (0)
- Cardiomyocytes? Do Mesenchymal Stromal Cells Transdifferentiate Into Functional (2011) (0)
- Hematopoietic cell transplants for indolent lymphomas (2017) (0)
- University of Groningen Reduced SLIT2 is Associated with Increased Cell Proliferation and Arsenic Trioxide Resistance in Acute Promyelocytic Leukemia Weinhäuser, (2020) (0)
- Increased CD68+ Macrophages Are Associated with Liver Fibrosis in a Humanized Chronic Graft-Versus-Host Disease Mouse Model (2015) (0)
- Biology: Critical components of hematopoietic cell transplantation (2017) (0)
- Assessment of comorbidities for hematopoietic cell transplants: Achievements and controversies (2017) (0)
- Cord blood cell transplants: Donor selection, volume, and controversies (2017) (0)
- Hematopoietic cell transplants for children with acute lymphoblastic leukemia (2017) (0)
- HYPOXIE MYOCARDIQUE , REPERFUSION , ACCIDENT VASCULAIRE CEREBRAL F 001 PROMINENT ROLE FOR THE ENDOTHELIAL GAP JUNCTION PROTEIN CONNEXIN 40 IN MYOCARDIAL ISCHEMIA-REPERFUSION INJURY IN MICE (2009) (0)
- Slit-Robo Pathway Is Clinically Relevant and May Represent a Potential Target in Acute Promyelocytic Leukemia (2018) (0)
- Making “Sense” Of Persistent Polyclonal B Cell Lymphocytosis (2013) (0)
- Novel Stem/Progenitor Populations: Implications for Cell Therapy (2009) (0)
- Phenotypic and Functional Characterization of Human Marrow Vascular Stromal Cells. (1999) (0)
- Metformintreatment Overcomes ATRA-Resistance in Acute Promyelocytic Leukemia and Increases FOXO3A Expression (2018) (0)
- Chimeric Mice Lacking Microsomal Prostaglandin E-2 Synthase-1 (mPGES) In Bone Marrow Develop Adverse Left Ventricular Remodelling After Myocardial Infarction (2008) (0)
- Irradiated NK-92 Targets AML Leukemic Stem Cells in Vivo and Gene-Modified CD16+NK-92 Mediates Antibody Dependent Cell Mediated Cytotoxicity (ADCC) Against CD123+ Cells (2012) (0)
- Peri-transplant imatinib administration results in significant mortality of recipients of allogeneic hematopoietic stem cell transplants due to impaired bone marrow recovery (2005) (0)
- 99: Predictors of Outcome of Mantle Cell Lymphoma in Patients with Progressive Disease following Autologous Stem Cell Transplantation (ASCT) (2008) (0)
- Transplantation of Haematopoietic Stem Cells (2007) (0)
- Osteogenesis and The Microenvironment. (1999) (0)
- Hematopoietic cell transplants for human immunodeficiency virus-related lymphomas (2017) (0)
- Hematopoietic cell transplants for bone marrow failure disorders (2017) (0)
- Autotransplants for neuroblastoma (2017) (0)
- NTAL is associated with treatment outcome, cell proliferation and differentiation in acute promyelocytic leukemia (2020) (0)
- Blood group incompatibilities and transfusion support after hematopoietic cell transplant (2017) (0)
- Statistics: Do we understand the results of our analyses? (2017) (0)
- Long-Term Results of Cytarabine-Containing Induction Followed By Consolidation with Autologous Stem Cell Transplant and Rituximab Maintenance As Primary Treatment for Mantle Cell Lymphoma (2015) (0)
- Long-term outcome following high-dose therapy with etoposide, melphalan, TBI and autologous stem cell transplantation (ASCT) for acute myeloid leukemia (AML). (2002) (0)
- COMMENTS ON : THORACIC RADIATION THERAPY BEFORE AUTOLOGOUS BONE MARROW TRANSPLANTATION IN RELAPSED OR REFRACTORY HODGKIN'S DISEASE. AUTHORS' REPLY (1999) (0)
- The role of membrane bound TNF in GVHD and GVT activity by alloreactive T cells (2006) (0)
- Humanized anti-CD123 antibody facilitates NK cell antibody-dependent cell-mediated cytotoxicity (ADCC) of Hodgkin lymphoma targets via ARF6/PLD-1 (2019) (0)
- Human mesenchymal stromal cells administered after radiotherapy and surgery in a soft tissue sarcoma mouse xenograft model do not promote local recurrence or metastasis (2018) (0)
- Late treatment mortality and secondary cancers after autologous stem cell transplant for relapsed or refractory Hodgkin lymphoma (HL) (2007) (0)
- Autoimmune Diseases : When Homeland Security Fails (2004) (0)
- Pre-autologous bone marrow transplant (ABMT) screening for HLA antibodies does not predict for platelet alloimmunization post-ABMT: A case controlled study (1997) (0)
- Qualitative difference in cd34 counts in multiple myeloma(mm) and breast cancer(bca) patient(pt) stem cell grafts (1997) (0)
- Mesenchymal Stem Cell Stimulation of Breast Cancer Proliferation Is Dependent on Both Stem Cell Source and Tumor Type. (2015) (0)
- Comparison o f P reparative R egimens i n T ransplants f or Children W ith A cute L ymphoblastic L eukemia (2000) (0)
- Letter to the Editor; Do mesenchymal stromal cells transdifferentiate into functional cardiomyocytes? (2009) (0)
- Development and characterization of a new inbred transgenic rat strain expressing DsRed monomeric fluorescent protein (2014) (0)
- T-cell depletion in allogeneic hematopoietic cell transplantation: Results, barriers, and future directions (2017) (0)
- Hematopoietic cell transplants for BCR/ABL negative acute lymphocytic leukemia (2017) (0)
- Population-based real-world registry study to evaluate clinical outcomes of chronic graft-versus-host disease (2023) (0)
- Meropenem Versus Cef taz id ime in the Treatment of Cancer (2000) (0)
- Unrelated Donor (URD) Hematopoietic Stem Cell Transplantation (HCT) for Adults with Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia (ALL) in First Complete Remission (CR1): A Center for International Blood and Marrow Transplant Research (CIBMTR) Analysis. (2007) (0)
- Editorial on "Specificity of Hematopoietic Stem and Progenitor Cell Homing to Bone Marrow: A Perspective", Cheryl Hardy. (2001) (0)
- Human Mesenchymal Stromal Cells (MSCs) Suppress Cytotoxicity of Natural Killer (NK) Cell Lines and Can Be Targets for NK-Mediated Cytolysis (2008) (0)
- Undertaking Regenerative Medicine Studies with Blood Stem Cells (2012) (0)
- Adoptive cell therapy for cancer using T-cells genetically engineered to express chimeric antigen receptors (2017) (0)
- Preliminary Results of FDG-PET Scanning after GDP Chemotherapy Prior to Autologous Stem Cell Transplant (ASCT) for Relapsed/Refractory (RR) Lymphoma (2016) (0)
- A Chemical Genetic Screen Identified Small Molecules Modulating Zebrafish Vascular Development and Angiogenesis. (2007) (0)
- Prevention and treatment of bacterial infections in hematopoietic cell transplants (2017) (0)
- Allogeneic hematopoietic cell transplants for BCR/ABL negative myeloproliferative neoplasms (2017) (0)
- Hematopoietic Cell Transplantation Donor Selection Reimagined: KIR-KIR Ligand Interactions and a Formalized Donor Risk Index Effective at Predicting Survival (2019) (0)
- Minimal residual disease in acute leukemias: Are we on the right path? (2017) (0)
- Effectiveness and tolerability of first-line autologous stem cell transplant and maintenance rituximab for mantle cell lymphoma (2018) (0)
- Platelet recovery after high-dose (HD) chemotherapy (C) is superior with peripheral blood stem cells (PBSC) mobilized by C + G-CSF compared to G-CSF alone (1997) (0)
- Characterization of the Stromal Extracellular Matrix: Editorial Comment on Dr. Verfaillie's Paper (1999) (0)
- The Role of BMT for AML in Relapse and Remission (1998) (0)
- Hematopoietic cell transplants for central nervous system lymphomas (2017) (0)
- Oct4 Expression and Mesenchymal Stromal Cell Plasticity (2008) (0)
- Hematopoietic cell transplants for chronic lymphocytic leukemia: Changing landscape? (2017) (0)
- Donor lymphocyte infusion: Rationale, benefits, and limitations (2017) (0)
- ASH Sets Scientific Priorities for the Next Three Years (2012) (0)
- Meropenem V ersus C eftazidime i n t he T reatment o f C ancer Patients W ith F ebrile N eutropenia: A R andomized, Double-Blind T rial (2000) (0)
- Immunophenotypic and functional characterisation of Mesodermal Killer (MK) cells: a novel cell type and potential cellular therapy for cancer (2020) (0)
- The Hematopoietic Microenvironment. (1999) (0)
- 86: Long-Term Follow-Up of Autologous Stem Cell Transplant (ASCT) in Patients with Mantle Cell Lymphoma (MCL) (2008) (0)
- Infectious diseases: Evaluation and implications of results in hematopoietic cell transplants (2017) (0)
- Treatment of COVID-19 with MSCs: how does it work? (2021) (0)
- Editorial Comment: Heterogeneity of Bone Marrow Stromal Cells Editorial Comment on Dr. Waller's Paper. (1999) (0)
- Unrelated donor selection: Human leukocyte antigen testing and matching _ permissive and non-permissive matches (2017) (0)
- Expert consensus on microtransplant for acute myeloid leukemia in elderly patients -report from the international microtransplant interest group. (2023) (0)
- Efficacy of NK-92 Against Human Multiple Myeloma in a NOD/SCID Gamma Null Mouse Model (2011) (0)
- Hematopoietic cell transplants for aggressive B-cell lymphomas (2017) (0)
- PS1534 EFFICACY AND SAFETY OF STEM CELL MOBILISATION FOLLOWING GDP SALVAGE IN PATIENTS WITH RELAPSED OR REFRACTORY LYMPHOMA (2019) (0)
- Autologous marrow and/or blood cell transplantation (ABMT) for follicular large cell lymphoma (FLC) (1997) (0)
- Contents, Vol. 6, 1986 (1986) (0)
- Safety of full dose anticoagulation in autologous stem cell transplantation (1997) (0)
- Conditioning regimens: Do they really matter? (2017) (0)
- Regenerative medicine: The future? (2017) (0)
- Editorial on “Specificity of Hematopoietic Stem and Progenitor Cell Homing to Bone Marrow: A Perspective”, Cheryl Hardy (2000) (0)
- Hematopoietic cell transplants for myelodysplastic syndromes (2017) (0)
- Low incidence of myelodysplasia or acute leukemia after autologous blood and marrow transplant without total body radiation for lymphoma (1997) (0)
- 9224 Role of salvage radiation therapy in Hodgkin Lymphoma with relapsed or progressive disease despite autologous stem cell transplant (2009) (0)
- Donor Mesenchymal Stromal Cells (MSCs) Undergo Variable Cardiac Reprogramming in Vivo and Predominantly Co-Express Cardiac and Stromal Determinants after Experimental Acute Myocardial Infarction (2013) (0)
- Acute Myeloblastic Leukemia: Management with High-Dose Cytosine Arabinoside, Daunorubicin and Marrow Transplantation; Malignancy; Current Clinical Practice. (2000) (0)
- A prospective cohort study comparing long-term outcomes with and without palifermin in patients receiving hematopoietic cell transplantation for hematologic malignancies. (2021) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Armand Keating?
Armand Keating is affiliated with the following schools:
